Regulatory Story
Company Cambria Africa PLC
Headline Appointment of Joint Broker
Released 08:18 04-Dec-2018
Number 3575J08

RNS Number : 3575J
Cambria Africa PLC
04 December 2018

04 December 2018

Cambria Africa Plc

('Cambria Africa' or 'the Company')


Appointment of Joint Broker


Cambria Africa Plc (AIM: CMB), the AIM listed investment company, with controlling interests in companies well-positioned to benefit from the growth and modernisation of Zimbabwe's economy, is pleased to announce the appointment of SVS Securities plc to act as its joint broker with immediate effect.

Cambria Africa is focused on investments in operating companies in Zimbabwe. Its wholly owned operations in Zimbabwe are:

·     Payserv Africa, a FINTECH company with $7.57 million in revenues in FY 2018. Payserv's Paynet Zimbabwe subsidiary is responsible for switching 40% of all financial transactions in Zimbabwe. It also has a significant presence in payroll management and consumer loan processing.

·     Millchem Zimbabwe, a value chemicals distributor with $1.87 million in revenues in FY 2018.

Cambria's unaudited preliminary consolidated earnings in FY 2018 were 0.52 US cents per share on revenues of US $9.44 million.





Cambria Africa Plc:


Samir Shasha

+44 (0) 207 669 0115






WH Ireland Limited:


James Joyce / Chris Viggor

+44 (0) 20 7220 1666



SVS Securities Plc                            

 +44 (0) 20 3700 0093

Tom Curran / Ben Tadd


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.